-
SciLifeLab’s unit Display and Selection Technologies which is part of the national research platform SciLifeLab Drug Discovery and Development . Its role, on a national level, is to focus on antibody
-
precision medicine and diagnostics covers data integration, analysis, visualization, and data interpretation for patient stratification, discovery of biomarkers for disease risks, diagnosis, drug response and
-
of steering cellular systems toward healthier states and transforming drug development to reduce trial-and-error and accelerate the translation of discoveries into clinical applications. DCS conducts
-
be embedded in a close collaboration with Ribocure, providing the candidate with valuable exposure to industrial drug development, insight into how academic discoveries are translated into medicines